Prevalence of human papillomavirus types in invasive cervical cancers from 7 us cancer registries before vaccine introduction

Journal of Lower Genital Tract Disease

Volumn 18, Issue 2, 2014, Pages 182-189

  Hopenhayn, Claudia ^a   Christian, Amy ^a   Christian, Warren Jay ^a   Watson, Meg ^b   Unger, Elizabeth R ^c   Lynch, Charles F ^d   Peters, Edward S ^e   Wilkinson, Edward J ^f   Huang, Youjie ^g   Copeland, Glenn ^h   Cozen, Wendy ⁱ   Saber, Maria Sibug ⁱ   Goodman, Marc T ^j   Hernandez, Brenda Y ^j   Steinau, Martin ^c   Lyu, Christopher ^k   Tucker, Thomas T ^a,l   Saraiya, Mona ^b  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g FLORIDA DEPARTMENT OF HEALTH   (United States)

^h MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^k BATTELLE MEMORIAL INSTITUTE   (United States)

^l UNIVERSITY OF KENTUCKY   (United States)

more..

Author keywords

HPV prevalence; HPV typing; human papillomavirus; invasive cervical cancer

Indexed keywords

EOSIN; HEMATOXYLIN; VIRUS DNA; WART VIRUS VACCINE;

ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CANCER REGISTRY; CONTROLLED STUDY; DNA EXTRACTION; ENDOMETRIUM CANCER; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 55; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 71; HUMAN PAPILLOMAVIRUS TYPE 72; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 83; HUMAN TISSUE; INVASIVE CERVICAL CANCER; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; RACE DIFFERENCE; STAINING; TISSUE SECTION; TUMOR INVASION; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CARCINOMA; VACCINATION; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PREVALENCE; REGISTRIES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84897582056     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182a577c7     Document Type: Article

References (27)

1. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22:2675-86.
2. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. United States Cancer Statistics: 1999-2008 Incidence & Mortality, WONDER Online Database. Available from: http://wonder.cdc.gov/cancer-v2008.html. Accessed February 21, 2012.
3. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol 2007; 109:360-70.
4. Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, et al. Using population-based cancer registry data to assess the burden of human papillomavirusY associated cancers in the United States: overview of methods. Cancer 2008;113:2841-54.
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
6. Dunne EF, Markowitz LE. Genital human papillomavirus infection. Clin Infect Dis 2006;43:624-9.
7. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Human Papillomavirus. Lyon, France: IARC; 2007.
8. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11: 1048-56.
9. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88:63-73.
10. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
11. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-32.
12. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24.
13. Saraiya M, Goodman MT, Datta SD, Chen VW, Wingo PA. Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role. Cancer 2008;113:3047-57.
14. Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine 2011;29:878-85.
15. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009;101:475-87.
16. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001;19:1906-15.
17. Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, et al. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 2008; 46:274-80.
18. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.
19. Castle PE, Shaber R, LaMere BJ, KinneyW, Fetterma B, Poitras N, et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev 2011; 20:946-53.
20. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2011;13:377-81.
21. Onyekwuluje JM, Steinau M, Swan DC, Unger ER. A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab 2012;58:61-6.
22. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011.
23. TjalmaWA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 2013;132:854-67.
24. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012;131:2349-59.
25. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:1611-22.
26. Alemany L, Perez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, et al. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention. Gynecol Oncol 2012;124:512-7.
27. US Department of Agriculture, Economic Research Service. 2003 Rural-Urban Continuum Codes. Available from: http://www.ers.usda.gov/Data/ RuralUrbanContinuumCodes/. Accessed August 1, 2012.